RCAMU
CDMO

Rothschild & Co Asset Management US’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Rothschild & Co Asset Management US’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$2.75M Sell
199,676
-1,931
-1% -$29.6K 0.04% 216
2022
Q3 		$3.85M Buy
201,607
+5,742
+3% +$105K 0.07% 201
2022
Q2 		$2.99M Buy
195,865
+55,945
+40% +$827K 0.05% 221
2022
Q1 		$2.85M Buy
+139,920
New +$2.85M 0.04% 228

Other funds holding CDMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Rothschild & Co Asset Management US's CDMO Position: Q4 2022 in Review

Rothschild & Co Asset Management US reduced its Avid Bioservices, Inc. Common Stock (CDMO) stake by 0.96% in Q4 2022, selling an estimated $29.6K and leaving 199,676 shares worth $2.75M. The position accounts for 0.04% of the portfolio, ranked #216.

Rothschild & Co Asset Management US first reported a position in CDMO in Q1 2022 and has held it in 4 quarters since. The position peaked at $3.85M in Q3 2022. 168 funds tracked by Wall St. Rank hold CDMO as of Q4 2022.

  • Rothschild & Co Asset Management US held 199,676 shares of Avid Bioservices, Inc. Common Stock worth $2.75M as of Q4 2022.
  • Rothschild & Co Asset Management US sold 1,931 Avid Bioservices, Inc. Common Stock shares in Q4 2022, an estimated $29.6K.
  • Avid Bioservices, Inc. Common Stock made up 0.04% of Rothschild & Co Asset Management US's portfolio in Q4 2022, its #216 holding.
  • Rothschild & Co Asset Management US first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2022 and has held it in 4 quarters since.
  • Rothschild & Co Asset Management US's Avid Bioservices, Inc. Common Stock position peaked at $3.85M in Q3 2022.
  • 168 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2022.

Based on Rothschild & Co Asset Management US's 13F filing for Q4 2022, filed 14 Feb 2023.